Obesity and the hepatic control of feeding behavior

Drug News and Perspectives

Volumn 20, Issue 9, 2007, Pages 573-578

  Friedman, Mark I ^a  

^a MONELL CHEMICAL SENSES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; FATTY ACID; FENOFIBRATE; MESSENGER RNA; NEUROPEPTIDE; NEUROTRANSMITTER;

APPETITE; ENERGY; FEEDING BEHAVIOR; FOOD INTAKE; HUMAN; IN VIVO STUDY; LIVER FUNCTION; NONHUMAN; OBESITY; OVERNUTRITION; OXIDATION; REVIEW; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; WEIGHT GAIN;

ANIMALS; ANTILIPEMIC AGENTS; APPETITE DEPRESSANTS; DRUG DESIGN; EATING; FEEDING BEHAVIOR; HUMANS; LIVER; OBESITY; SIGNAL TRANSDUCTION;

EID: 41649116419     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2007.20.9.1162243     Document Type: Review

References (61)

1. Russek, M. An hypothesis on the participation of hepatic glucoreceptors in the control of food intake. Nature 1963, 197: 79-80.
2. Russek, M. Current status of the hepatostatic theory of food intake control. Appetite 1981, 2(2): 137-43.
3. Tordoff, M.G. and Friedman, M.I. Hepatic portal glucose infusions decrease food intake and increase food preference. Am J Physiol 1986, 251(1 Pt. 2): R191-R6.
4. Novin, D., VanderWeele, D.A. and Rezek, M. Infusion of 2-deoxy-D-glucose into the hepatic-portal system causes eating: Evidence for peripheral glucoreceptors. Science 1973, 181(102): 858-60.
5. Tordoff, M.G., Tluczek, J.P. and Friedman, M.I. Effect of hepatic portal glucose concentration on food intake and metabolism. Am J Physiol 1990, 257(6 Pt. 2): R1474-80.
6. Baird, J-P., Grill, H.J. and Kaplan, J.M. Intake suppression after hepatic-portal glucose infusion: All-or-none effect and its temporal threshold. Am J Physiol 1997, 272(5 Pt. 2): R1454-60.
7. Anil, M.H. and Forbes, J.M. Feeding in sheep during intraportal infusions of short-chain fatty acids and the effect of liver denervation. J Physiol 1980, 298: 407-14.
8. Jambor de Sousa, U.L., Benthem, L., Arsenijevic, D., Scheurink, A.J., Langhans, W., Geary, N. and Leonhardt, M. Hepatic-portal oleic acid inhibits feeding more potently than hepatic-portal caprylic acid in rats. Physiol Behav 2006, 89(3): 329-34.
9. Tordoff, M.G. and Friedman, M.I. Hepatic control of feeding: Effect of glucose, fructose and mannitol infusion. Am J Physiol 1988, 254(6 Pt. 2): R969-76.
10. Tordoff, M.G., Rawson, N.E. and Friedman, M.I. 2,5-Anhydro-D-mannitol acts in liver to initiate feeding. Am J Physiol 1991, 261(2 Pt. 2): R283-8.
11. Rawson, N.E., Blum, H., Osbakken, M.D. and Friedman, M.I. Hepatic phosphate trapping, decreased ATP and increased feeding after 2,5-anhydro-D-mannitol. Am J Physiol 1994, 266(1 Pt. 2): R112-7.
12. Koch, J.E., Ji, H., Osbakken, M.D. and Friedman, M.I. Temporal relationships between eating behavior and liver adenine nucleotides in rats treated with 2,5-anhydro-D-mannitol. Am J Physiol 1998, 274(3 Pt. 2): R610-7.
13. Rawson, N.E. and Friedman, M.I. Phosphate-loading prevents the decrease in ATP and increase in food intake produced by 2,5-anhydro-D-mannitol. Am J Physiol 1994, 266(6Pt. 2): R1792-6.
14. Rawson, N.E., Ulrich, P.M. and Friedman, M.I. L-Ethionine, an amino acid analogue, stimulates eating in rats. Am J Physiol 1994, 267(2 Pt. 2): R612-5.
15. Rawson, N.E., Ulrich, P.M. and Friedman, M.I. Fatty acid oxidation modulates the eating response to the fructose analogue, 2,5-anhydro-D-mannitol. Am J Physiol 1996, 271(1 Pt. 2): R144-8.
16. Friedman, M.I., Koch, J.E., Graczyk-Milbrandt, G., Ulrich, P.M. and Osbakken, M.D. High-fat diet prevents eating response and attenuates liver ATP decline in rats given 2,5-anhydro-D-mannitol. Am J Physiol 2002, 282: R710-4.
17. Ji, H., Graczyk-Milbrandt, G. and Friedman, M.I. Metabolic inhibitors synergistically decrease hepatic energy status and increase food intake. Am J Physiol 2000, 278(6): R1579-82.
18. Horn, C.C., Ji, H. and Friedman, M.I. Etomoxir, a fatty acid oxidation inhibitor, increases food intake and reduces hepatic energy status in rats. Physiol Behav 2004, 81(1): 157-62.
19. Friedman, M.I., Harris, R.B., Ji, H., Ramirez, I. and Tordoff, M.G. Fatty acid oxidation affects food intake by altering hepatic energy status. Am J Physiol 1999, 276(4 Pt. 2): R1046-53.
20. Ji, H. and Friedman, M.I. Compensatory hyperphagia after fasting tracks recovery of liver energy status. Physiol Behav 1999, 68(1-2): 181-6.
21. Friedman, M.I., Graczyk-Millbrandt, G., Ji, H., Rawson, N.E. and Osbakken, M.D. 2,5-Anhydro-D-mannitol increases hepatocyte sodium: Transduction of a hepatic hunger stimulus? Biochim Biophys Acta 2003, 1642(1-2): 53-8.
22. Langhans W. and Scharrer, E. Evidence for a role of the sodium pump of hepatocytes in the control of food intake. J Auton Nerv Syst 1987, 20(3): 199-205.
23. Lutz, T.A., Boutellier, S. and Scharrer, E. Hyperpolarizalion of the rat hepatocyte membrane by 2,5-anhydro-D-mannitol in vivo. Life Sci 1998, 62(16): 1427-32.
24. Rawson, N.E., Ji, H. and Friedman, M.I. Anhydro-D-mannitol increases hepatocyte calcium: Implications for a hepatic hunger stimulus. Biochim Biophys Acta 2003, 1642(1-2): 59-66.
25. Niijima, A. Sensing of energy substrates, electrolytes and hormones by hepatic afferent nerves. In: Liver and Nervous System. D. Häussinger, K. Jungermann (Eds.). Kluwer: Lancaster 1998, 159-72.
26. Lutz, T.A., Niijima, A. and Scharrer, E. Intraportal infusion of 2,5-anhydro-D-mannitol increases afferent activity in the common hepatic vagus branch. J Auton Nerv Syst 1996, 61(2): 204-8.
27. Lutz, T.A., Diener, M. and Scharrer, E. Intraportal mercaptoacetate infusion increases afferent activity in the common hepatic vagus branch of the rat. Am J Physiol 1997, 273(1 Pt. 2): R442-5.
28. Ritter, S., Dihn, T.T. and Friedman, M.I. Induction of Fos-like immunoreactivity (Fos-li) and stimulation of feeding by 2,5-anhydro-D-mannitol (2,5-AM) require the vagus nerve. Brain Res 1994, 646(1): 53-64.
29. Langhans, W. and Scharrer, E. Evidence for a vagally mediated satiety signal derived from hepatic fatty acid oxidation. J Auton Nerv Syst 1987, 18(1): 13-8.
30. Horn, C.C. and Friedman, M.I. Methyl palmoxirate increases eating behavior and brain fos-like immunoreactivity in rats. Brain Res 1998, 781(1-2): 8-14.
31. Horn, C.C., Aleymayehu, A. and Friedman, M.I. Neural substrate for an integrated metabolic control of feeding behavior. Am J Physiol 1999, 276(1 Pt. 2): R113-9.
32. Geary, N., Le Sauter, J. and Noh, U. Glucagon acts in liver to control spontaneous meal size in rats. Am J Physiol 1993, 264(1 Pt. 2): R116-22.
33. Friedman, M.I. and Sawchenko, P.E. Evidence for hepatic involvement in the control of ad libitum food intake in rats. Am J Physiol 1984, 247(1 Pt. 2): R106-13.
34. Levin, B.E. Reduced norepinephrine turnover in organs and brains of obesity-prone rats. Am J Physiol 1995, 268(2 Pt. 2): R389-94.
35. Heitmann, B.L., Lissner, L., Sorensen, T.I. and Bengtsson, C. Dietary fat intake and weight gain in women genetically predisposed for obesity. Am J Clin Nutr 1995, 61(6): 1213-7.
36. Schemmel, R., Mickelsen, O. and Gill, J.L. Dietary obesity in rats: Body weight and body fat accretion in seven strains of rats. J Nutr 1970, 100(9): 1041-8.
37. West, D.B., Boozer, C.N., Moody, D.L. and Atkinson, R.L. Dietary obesity in nine inbred mouse strains. Am J Physiol 1992, 262(6Pt. 2): R1025-32.
38. Levin, B.E., Dunn-Meynell, A.A., Balkan, B. and Keesey, R.E. Selective breeding for diet-induced obesity and resistance in Sprague- Dawley rats. Am J Physiol 1997, 273(2 Pt. 2): R725-30.
39. Ravussin, E. and Gautier, J-F. Metabolic predictors of weight gain. Int J Obesity 1999, 23(Suppl. 1): 37-41.
40. Ji, H. and Friedman, M.I. Fasting plasma triglyceride levels and fat oxidation predict dietary obesity in rats. Physiol Behav 2003, 78(4-5): 767-72.
41. Ji, H. and Friedman, M.I. Reduced capacity for fatty acid oxidation in rats with inherited susceptibility to diet-induced obesity. Metabolism 2007, 56(8): 1124-30.
42. Ji, H., Outterbridge, L.V. and Friedman, M.I. Phenotype-based treatment for dietary obesity: Differential effects of fenofibrate in obesity-prone and obesity-resistant rats. Metabolism 2005, 54(4): 421-9.
43. Kim, S., Sohn, I., Lee, Y.S. and Lee, Y.S. Hepatic gene expression profiles are altered by genistein supplementation in mice with diet-induced obesity. J Nutr 2005, 135(1): 33-41.
44. Thupari, J.N., Kim, E.K., Moran, T.H., Ronnett, G.V. and Kuhajda, F.P. Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass. Am J Physiol Endocrinol Metab 2004, 287(1): E97-E104.
45. Jbilo, O., Ravinet-Trillou, C., Arnone, M., et al. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through regulation of lipolysis and energy balance. FASEB J 2005, 19(11): 1567-9.
46. Friedman, M.I. Hyperphagia in rats with experimental diabetes mellitus: A response to a decreased supply of utilizable fuels. J Comp Physiol Psychol 1978, 92(1): 109-17.
47. Friedman, M.I., Ramirez, I., Edens, N.K. and Granneman, J. Food intake in diabetic rats: Isolation of primary metabolic effects of fat feeding. Am J Physiol 1985, 249(1 Pt. 2): R4451.
48. Scharrer, E. and Langhans, W. Control of food intake by fatty acid oxidation. Am J Physiol 1986, 250(6 Pt. 2): R1003-6.
49. Leonhardt, M. and Langhans, W. Fatty acid oxidation and control of food intake. Physiol Behav 2004, 83(4): 645-51.
50. Horn, C.C., Tordoff, M.G. and Friedman, M.I. Role of vagal afferent innervation in feeding and brain Fos expression produced by metabolic inhibitors. Brain Res 2001, 919(2): 198-206.
51. 1a Fleur, S.E., Ji, H., Manalo, S.L., Friedman, M.I. and Dallman, M.F. The hepatic vagus mediates fat-induced inhibition of diabetic hyperphagia. Diabetes 2003, 52(9): 2321-30.
52. Warne, J.P., Foster, M.T., Horneman, H.F., Pecoraro, N.C., Ginsberg, A.B., Akana, S.F. and Dallman, M.F. Afferent signaling through the common hepatic branch of the vagus inhibits voluntary lard intake and modifies plasma metabolite levels in rats. J Physiol 2007, 583(Pt. 2): 455-67.
53. Cortez-Pinto, H., Chatham, J., Chacko, V.P., Arnold, C., Rashid, A. and Diehl, A.M. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis. JAMA 1999, 282(17): 1659-64.
54. Nair, S., Chacko, V.P., Arnold, C. and Diehl, A.M. Hepatic ATP reserve and efficiency of replenishing: Comparison between obese and nonobese normal individuals. Am J Gastroenterol 2003, 98(2): 466-70.
55. Zarjevski, N., Cusin, I., Vettor, R., Rohner-Jeanrenaud, F. and Jeanrenaud, J. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 1993, 133(4): 1753-8.
56. Adage, T., Scheurink, A.J., de Boer, S.F. et al. Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats. J Neurosci 2001, 21(10): 3639-45.
57. Pocai, A., Morgan, K., Buettner, C., Gutierrez-Juarez, R., Obici, S. and Rossetti, L. Central leptin acutely reverses diet-induced hepatic insulin resistance. Diabetes 2005, 54(11): 3182-9.
58. Inoue, H., Ogawa, W., Asakawa, A. et al. Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab 2006, 3(4): 267-75.
59. Plum, L., Belgardt, B.F. and Bruning J.C. Central insulin action in energy and glucose homeostasis. J Clin Invest 2006, 116(7): 1761-6.
60. Otukonyong, E.E., Dube, M.G., Torto, R., Kalra, P.S. and Kalra, S.P. Central leptin differentially modulates ultradian secretory patterns of insulin, leptin and ghrelin independent of effects on food intake and body weight. Peptides 2005, 26(12): 2559-66.
61. Theander-Carrillo, C., Wiedmer, P., Cettour-Rose, P., et al. Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 2006, 116(7): 1983-93.